These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9231076)

  • 21. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
    Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA
    Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of bovine leukemia virus protein p24 in Escherichia coli and its use in the immunoblotting assay.
    Bicka L; Kuźmak J; Kozaczyńska B; Plucienniczak A; Skorupska A
    Acta Biochim Pol; 2001; 48(1):227-32. PubMed ID: 11440174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exogenous peptide and protein expression levels using retroviral vectors in human cells.
    Sandrock TM; Risley B; Richards BT; Poritz MA; Austin HA; Yoo S; Kim MK; Roth B; Repetny K; Hsu F; Stump M; Teng DH; Kamb A
    Mol Ther; 2001 Nov; 4(5):398-406. PubMed ID: 11708876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral vector targeting for gene therapy.
    Günzburg WH; Fleuchaus A; Saller R; Salmons B
    Cytokines Mol Ther; 1996 Sep; 2(3):177-84. PubMed ID: 9384702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
    Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
    Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Capsid-targeted viral inactivation for dengue virus infection].
    Qin CF; Jiang T; Chen SP; Yu M; Qin ED
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):111-5. PubMed ID: 15847175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
    J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-entry restriction of retroviral infections.
    Towers GJ; Goff SP
    AIDS Rev; 2003; 5(3):156-64. PubMed ID: 14598564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
    Zavorotinskaya T; Albritton LM
    Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
    Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
    Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of rat bone marrow cells by Friend murine leukemia virus envelope proteins.
    Mazgareanu S; Müller JG; Czub S; Schimmer S; Bredt M; Czub M
    Virology; 1998 Mar; 242(2):357-65. PubMed ID: 9514963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of enzyme-linked immunosorbent assay for detecting antibodies to replication-competent murine leukemia virus.
    Kim S; Park EJ; Yu SS; Kim S
    J Virol Methods; 2004 Jun; 118(1):1-7. PubMed ID: 15158062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine models for antiretroviral therapy.
    Ruprecht RM
    Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Destroying retroviruses from within.
    Boeke JD; Hahn B
    Trends Microbiol; 1996 Nov; 4(11):421-6. PubMed ID: 8950810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-step separation of myristoylated and nonmyristoylated retroviral matrix proteins.
    Doležal M; Zábranský A; Hrabal R; Ruml T; Pichová I; Rumlová M
    Protein Expr Purif; 2013 Nov; 92(1):94-9. PubMed ID: 24056256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical analysis of retroviral structural proteins to identify and quantify retrovirus expressed by an NS0 murine myeloma cell line.
    Taylor FR; Ferrant JL; Foley SF; Zeng C; Sernatinger J; Juffras R; Pepinsky RB
    J Biotechnol; 2001 Nov; 84(1):33-43. PubMed ID: 11035185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abrogation of Ref1 retrovirus restriction in human cells.
    Towers G; Collins M; Takeuchi Y
    J Virol; 2002 Mar; 76(5):2548-50. PubMed ID: 11836433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of xenotropic murine leukemia virus-related retrovirus in chronic fatigue syndrome and prostate cancer: reach for a scorecard, not a prescription pad.
    Kearney M; Maldarelli F
    J Infect Dis; 2010 Nov; 202(10):1463-6. PubMed ID: 20936981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.